- Book
- August 2013
- 386 Pages
- Book
- February 2013
- 512 Pages
- Book
- August 2012
- 552 Pages
- Book
- September 2010
- 484 Pages
- Book
- September 2010
- 984 Pages
- Book
- October 2009
- 912 Pages
- Book
- September 2009
- 306 Pages
- Book
- November 2008
- 312 Pages
- Book
- January 2007
- 488 Pages
- Book
- April 2024
- 144 Pages
- Book
- October 2022
- 400 Pages
- Book
- June 2022
- 336 Pages
- Book
- March 2021
- 320 Pages
- Book
- August 2018
- 352 Pages
- Book
- June 2015
- 392 Pages
- Book
- November 2013
- 744 Pages
- Book
- May 2013
- 192 Pages
- Book
- August 2010
- 656 Pages
- Book
- March 2010
- 720 Pages
- Book
- March 2008
- 352 Pages
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more